| Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial F Edelmann, R Wachter, AG Schmidt, E Kraigher-Krainer, C Colantonio, ... Jama 309 (8), 781-791, 2013 | 889 | 2013 |
| Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in … F Edelmann, G Gelbrich, HD Düngen, S Fröhling, R Wachter, ... Journal of the American College of Cardiology 58 (17), 1780-1791, 2011 | 818 | 2011 |
| Left ventricular heart failure and pulmonary hypertension S Rosenkranz, JSR Gibbs, R Wachter, T De Marco, A Vonk-Noordegraaf, ... European heart journal 37 (12), 942-954, 2016 | 776 | 2016 |
| Screening for atrial fibrillation: a report of the AF-SCREEN international collaboration B Freedman, J Camm, H Calkins, JS Healey, M Rosenqvist, J Wang, ... Circulation 135 (19), 1851-1867, 2017 | 655 | 2017 |
| Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial UC Hoppe, MC Brandt, R Wachter, J Beige, LC Rump, AA Kroon, ... Journal of the American Society of Hypertension 6 (4), 270-276, 2012 | 397 | 2012 |
| Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study R Wachter, M Senni, J Belohlavek, E Straburzynska‐Migaj, KK Witte, ... European journal of heart failure 21 (8), 998-1007, 2019 | 389 | 2019 |
| Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association … TM Gorter, DJ van Veldhuisen, J Bauersachs, BA Borlaug, J Celutkiene, ... European journal of heart failure 20 (1), 16-37, 2018 | 377 | 2018 |
| Improved detection of silent atrial fibrillation using 72-hour Holter ECG in patients with ischemic stroke: a prospective multicenter cohort study M Grond, M Jauss, G Hamann, E Stark, R Veltkamp, D Nabavi, M Horn, ... Stroke 44 (12), 3357-3364, 2013 | 368 | 2013 |
| A short form of the General Self-Efficacy Scale (GSE-6): Development, psychometric properties and validity in an intercultural non-clinical sample and a sample of patients at … M Romppel, C Herrmann-Lingen, R Wachter, F Edelmann, HD Düngen, ... GMS Psycho-Social-Medicine 10, 2013 | 301 | 2013 |
| Effect of escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression: the MOOD-HF randomized clinical trial CE Angermann, G Gelbrich, S Störk, H Gunold, F Edelmann, R Wachter, ... Jama 315 (24), 2683-2693, 2016 | 299 | 2016 |
| Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction WT Abraham, MR Zile, FA Weaver, C Butter, A Ducharme, M Halbach, ... JACC: Heart Failure 3 (6), 487-496, 2015 | 297 | 2015 |
| Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double‐blind, randomized comparison of two uptitration regimens M Senni, JJV McMurray, R Wachter, HF McIntyre, A Reyes, I Majercak, ... European journal of heart failure 18 (9), 1193-1202, 2016 | 296 | 2016 |
| Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial R Wachter, K Groeschel, G Gelbrich, GF Hamann, P Kermer, J Liman, ... The Lancet Neurology 16 (4), 282-290, 2017 | 294 | 2017 |
| Incidence of previously undiagnosed atrial fibrillation using insertable cardiac monitors in a high-risk population: the REVEAL AF study JA Reiffel, A Verma, PR Kowey, JL Halperin, BJ Gersh, R Wachter, ... JAMA cardiology 2 (10), 1120-1127, 2017 | 281 | 2017 |
| Enhanced detection of paroxysmal atrial fibrillation by early and prolonged continuous holter monitoring in patients with cerebral ischemia presenting in sinus rhythm R Stahrenberg, M Weber-Krüger, J Seegers, F Edelmann, R Lahno, ... Stroke 41 (12), 2884-2888, 2010 | 272 | 2010 |
| Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS‐ELD trial HD Düngen, S Apostolović, S Inkrot, E Tahirović, A Töpper, F Mehrhof, ... European journal of heart failure 13 (6), 670-680, 2011 | 260* | 2011 |
| Searching for atrial fibrillation poststroke: a white paper of the AF-SCREEN international collaboration RB Schnabel, KG Haeusler, JS Healey, B Freedman, G Boriani, ... Circulation 140 (22), 1834-1850, 2019 | 257 | 2019 |
| Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life T Bekfani, P Pellicori, DA Morris, N Ebner, M Valentova, L Steinbeck, ... International journal of cardiology 222, 41-46, 2016 | 236 | 2016 |
| RAnoLazIne for the treatment of diastolic heart failure in patients with preserved ejection fraction: the RALI-DHF proof-of-concept study LS Maier, B Layug, E Karwatowska-Prokopczuk, L Belardinelli, S Lee, ... JACC: Heart Failure 1 (2), 115-122, 2013 | 231 | 2013 |
| Galectin‐3 in patients with heart failure with preserved ejection fraction: results from the Aldo‐DHF trial F Edelmann, V Holzendorf, R Wachter, K Nolte, AG Schmidt, ... European journal of heart failure 17 (2), 214-223, 2015 | 219 | 2015 |
